Ansun BioPharma Closes $85 Million Series A Financing
May 14, 2018
Ansun Biopharma, based in San Diego, closed on a Series A financing round worth $85 million. The round was led by Sinopharm Healthcare Fund and Lilly Asia Ventures. New investors included Oceanpine Capital, Lyfe Capital, Yuanming Capital, Matrix Partners